Pak approves China’s Sinopharm vaccine for emergency use


Staff Reporter


The Drug Regulatory Authority (DRAP) on Monday authorised China’s Sinopharm Covid-19 vaccine for emergency use in Pakistan, making it the second vaccine to get local approval.
The permission was given in the DRAP registration board meeting after China’s Sinopharm sought permission from Pakistan for the emergency use of its Covid-19 vaccine in the country, a news channel said.
Sinopharm, a state-run Chinese firm, is developing two Covid-19 vaccines. Pakistan will purchase 1.2 million doses of the corona vaccine from China.
Pakistan is also running phase III clinical trials of another Chinese vaccine from CanSino Biologics’, led by the National Institute of Health.
Meanwhile, Pakistan has reported 46 more coronavirus-related deaths in past 24 hours, surging the overall death toll to 10,977.

Previous articleCabinet meets today
Next articleAssets case: ECP suspends membership of 154 MPs